Financial Highlights
• December quarterly sales of $7.9m were up by 50.1% vs the corresponding December 2019 quarter, and increased 34.2% vs the preceding September 2020 quarter,
• Biopolymer sales were up 71.1% from the September 2020 quarter and now represent over 73.3% of total sales,
• Driven by record biopolymer sales, SECOS expects to report a maiden profit for the first half for FY21,
• SECOS reported a net operating cash outflow of $1.4 million in December 2020 quarter after investing over $2.6 million in new working capital to support increasing sales volumes,
• The Balance Sheet remains strong with $14.3 million in cash and no debt,
• Capex investment continues with additional extrusion and bagging lines in China and Malaysia to support increased demand.
Disc : I hold on Strawman and TRW